Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report) shares reached a new 52-week high during trading on Friday . The company traded as high as $368.45 and last traded at $368.45, with a volume of 11 shares changing hands. The stock had previously closed at $334.85.
Bio-Rad Laboratories Price Performance
The company has a quick ratio of 4.52, a current ratio of 6.14 and a debt-to-equity ratio of 0.16. The company has a market cap of $10.27 billion, a price-to-earnings ratio of -12.25 and a beta of 0.73. The stock’s 50-day simple moving average is $332.14 and its 200 day simple moving average is $306.31.
Bio-Rad Laboratories Company Profile
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
See Also
- Five stocks we like better than Bio-Rad Laboratories
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- What Are Dividend Challengers?
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- Manufacturing Stocks Investing
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
